trontinemab: Administer trontinemab or placebo intravenously according to the protocol.

2 trials

Sponsors

Christopher Lane

Conditions

Alzheimers disease

Phase 3

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

RecruitingJPRN-jRCT2031250328

Christopher LaneAlzheimers disease

Start: 2025-11-10Target: 800Updated: 2026-06-29

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

RecruitingJPRN-jRCT2031250327

Christopher LaneAlzheimers disease

Start: 2025-12-03Target: 800Updated: 2026-06-29